HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Necrobiotic Xanthogranuloma

A cutaneous necrobiotic disorder characterized by firm, yellow plaques or nodules, often in a periorbital distribution. It is often accompanied by an elevated ERYTHROCYTE SEDIMENTATION RATE; LEUKOPENIA; and MONOCLONAL GAMMOPATHY (IgG-kappa type) and systemic involvement.
Also Known As:
Necrobiotic Xanthogranulomas; Xanthogranuloma, Necrobiotic; Xanthogranulomas, Necrobiotic
Networked: 93 relevant articles (8 outcomes, 1 trials/studies)

Relationship Network

Disease Context: Research Results

Related Diseases

1. Multiple Myeloma
2. Neurologic Manifestations (Neurological Manifestations)
3. Gilbert Disease
4. Paraproteinemias (Monoclonal Gammopathy)
5. Necrobiotic Disorders (Necrobiosis)

Experts

1. Elsner, Peter: 2 articles (01/2017 - 09/2005)
2. Rosenbach, Misha: 2 articles (03/2016 - 01/2016)
3. Ziemer, Mirjana: 2 articles (09/2010 - 09/2005)
4. Chave, T A: 2 articles (09/2001 - 01/2001)
5. Agrawal, Sahil: 1 article (03/2022)
6. Das, Deepsekhar: 1 article (03/2022)
7. Modaboyina, Sujeeth: 1 article (03/2022)
8. Pushker, Neelam: 1 article (03/2022)
9. Ali, F R: 1 article (01/2022)
10. Haubner, Frank: 1 article (01/2022)

Drugs and Biologics

Drugs and Important Biological Agents (IBA) related to Necrobiotic Xanthogranuloma:
1. Dexamethasone (Maxidex)FDA LinkGeneric
2. Bortezomib (Velcade)FDA Link
3. Melphalan (Alkeran)FDA LinkGeneric
4. Prednisolone (Predate)FDA LinkGeneric
5. Lenalidomide (CC 5013)FDA Link
6. InterferonsIBA
7. Immunoglobulins (Immunoglobulin)IBA
8. Ointments (Pastes)IBA
9. Ficusin (Psoralen)IBA
10. BilirubinIBA

Therapies and Procedures

1. Therapeutics
2. Radiotherapy
3. Plasmapheresis
4. Drug Therapy (Chemotherapy)
5. Off-Label Use